Global Small Molecule Targeted Cancer Therapy Market Growth (Status and Outlook) 2025-2031

February 2025 | 127 pages | ID: G52B00C68A07EN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
  2.1.2 Small Molecule Targeted Cancer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Small Molecule Targeted Cancer Therapy by Country/Region (2020, 2024 & 2031)
2.2 Small Molecule Targeted Cancer Therapy Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Small Molecules
  2.2.3 Small Molecule Drug Conjugates
2.3 Small Molecule Targeted Cancer Therapy Market Size by Type
  2.3.1 Small Molecule Targeted Cancer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
2.4 Small Molecule Targeted Cancer Therapy Segment by Application
  2.4.1 Lymphoma
  2.4.2 Melanoma
  2.4.3 Multiple Myeloma
  2.4.4 Breast Cancer
  2.4.5 Prostate Cancer
  2.4.6 Others
2.5 Small Molecule Targeted Cancer Therapy Market Size by Application
  2.5.1 Small Molecule Targeted Cancer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)

3 SMALL MOLECULE TARGETED CANCER THERAPY MARKET SIZE BY PLAYER

3.1 Small Molecule Targeted Cancer Therapy Market Size Market Share by Player
  3.1.1 Global Small Molecule Targeted Cancer Therapy Revenue by Player (2020-2025)
  3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Small Molecule Targeted Cancer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SMALL MOLECULE TARGETED CANCER THERAPY BY REGION

4.1 Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025)
4.2 Global Small Molecule Targeted Cancer Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Small Molecule Targeted Cancer Therapy Market Size Growth (2020-2025)
4.4 APAC Small Molecule Targeted Cancer Therapy Market Size Growth (2020-2025)
4.5 Europe Small Molecule Targeted Cancer Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
5.2 Americas Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025)
5.3 Americas Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025)
6.2 APAC Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025)
6.3 APAC Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Small Molecule Targeted Cancer Therapy by Region (2020-2025)
8.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SMALL MOLECULE TARGETED CANCER THERAPY MARKET FORECAST

10.1 Global Small Molecule Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.1.1 Global Small Molecule Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Small Molecule Targeted Cancer Therapy Forecast
  10.1.3 APAC Small Molecule Targeted Cancer Therapy Forecast
  10.1.4 Europe Small Molecule Targeted Cancer Therapy Forecast
  10.1.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Forecast
10.2 Americas Small Molecule Targeted Cancer Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Small Molecule Targeted Cancer Therapy Forecast
  10.2.2 Canada Market Small Molecule Targeted Cancer Therapy Forecast
  10.2.3 Mexico Market Small Molecule Targeted Cancer Therapy Forecast
  10.2.4 Brazil Market Small Molecule Targeted Cancer Therapy Forecast
10.3 APAC Small Molecule Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.3.1 China Small Molecule Targeted Cancer Therapy Market Forecast
  10.3.2 Japan Market Small Molecule Targeted Cancer Therapy Forecast
  10.3.3 Korea Market Small Molecule Targeted Cancer Therapy Forecast
  10.3.4 Southeast Asia Market Small Molecule Targeted Cancer Therapy Forecast
  10.3.5 India Market Small Molecule Targeted Cancer Therapy Forecast
  10.3.6 Australia Market Small Molecule Targeted Cancer Therapy Forecast
10.4 Europe Small Molecule Targeted Cancer Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Small Molecule Targeted Cancer Therapy Forecast
  10.4.2 France Market Small Molecule Targeted Cancer Therapy Forecast
  10.4.3 UK Market Small Molecule Targeted Cancer Therapy Forecast
  10.4.4 Italy Market Small Molecule Targeted Cancer Therapy Forecast
  10.4.5 Russia Market Small Molecule Targeted Cancer Therapy Forecast
10.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Small Molecule Targeted Cancer Therapy Forecast
  10.5.2 South Africa Market Small Molecule Targeted Cancer Therapy Forecast
  10.5.3 Israel Market Small Molecule Targeted Cancer Therapy Forecast
  10.5.4 Turkey Market Small Molecule Targeted Cancer Therapy Forecast
10.6 Global Small Molecule Targeted Cancer Therapy Forecast by Type (2026-2031)
10.7 Global Small Molecule Targeted Cancer Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Small Molecule Targeted Cancer Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Small Molecule Targeted Cancer Therapy Product Offered
  11.1.3 Roche Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Gilead Sciences
  11.2.1 Gilead Sciences Company Information
  11.2.2 Gilead Sciences Small Molecule Targeted Cancer Therapy Product Offered
  11.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Gilead Sciences Main Business Overview
  11.2.5 Gilead Sciences Latest Developments
11.3 Boehringer Ingelheim
  11.3.1 Boehringer Ingelheim Company Information
  11.3.2 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Product Offered
  11.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Boehringer Ingelheim Main Business Overview
  11.3.5 Boehringer Ingelheim Latest Developments
11.4 Abbott Laboratories
  11.4.1 Abbott Laboratories Company Information
  11.4.2 Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Offered
  11.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Abbott Laboratories Main Business Overview
  11.4.5 Abbott Laboratories Latest Developments
11.5 Bayer AG
  11.5.1 Bayer AG Company Information
  11.5.2 Bayer AG Small Molecule Targeted Cancer Therapy Product Offered
  11.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bayer AG Main Business Overview
  11.5.5 Bayer AG Latest Developments
11.6 GSK
  11.6.1 GSK Company Information
  11.6.2 GSK Small Molecule Targeted Cancer Therapy Product Offered
  11.6.3 GSK Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 GSK Main Business Overview
  11.6.5 GSK Latest Developments
11.7 AstraZeneca
  11.7.1 AstraZeneca Company Information
  11.7.2 AstraZeneca Small Molecule Targeted Cancer Therapy Product Offered
  11.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 AstraZeneca Main Business Overview
  11.7.5 AstraZeneca Latest Developments
11.8 Johnson & Johnson
  11.8.1 Johnson & Johnson Company Information
  11.8.2 Johnson & Johnson Small Molecule Targeted Cancer Therapy Product Offered
  11.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Johnson & Johnson Main Business Overview
  11.8.5 Johnson & Johnson Latest Developments
11.9 Teva
  11.9.1 Teva Company Information
  11.9.2 Teva Small Molecule Targeted Cancer Therapy Product Offered
  11.9.3 Teva Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Teva Main Business Overview
  11.9.5 Teva Latest Developments
11.10 Pfizer
  11.10.1 Pfizer Company Information
  11.10.2 Pfizer Small Molecule Targeted Cancer Therapy Product Offered
  11.10.3 Pfizer Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Pfizer Main Business Overview
  11.10.5 Pfizer Latest Developments
11.11 Allergan
  11.11.1 Allergan Company Information
  11.11.2 Allergan Small Molecule Targeted Cancer Therapy Product Offered
  11.11.3 Allergan Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Allergan Main Business Overview
  11.11.5 Allergan Latest Developments
11.12 Merck
  11.12.1 Merck Company Information
  11.12.2 Merck Small Molecule Targeted Cancer Therapy Product Offered
  11.12.3 Merck Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Merck Main Business Overview
  11.12.5 Merck Latest Developments
11.13 Novartis
  11.13.1 Novartis Company Information
  11.13.2 Novartis Small Molecule Targeted Cancer Therapy Product Offered
  11.13.3 Novartis Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Novartis Main Business Overview
  11.13.5 Novartis Latest Developments
11.14 Sanofi
  11.14.1 Sanofi Company Information
  11.14.2 Sanofi Small Molecule Targeted Cancer Therapy Product Offered
  11.14.3 Sanofi Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Sanofi Main Business Overview
  11.14.5 Sanofi Latest Developments
11.15 Amgen
  11.15.1 Amgen Company Information
  11.15.2 Amgen Small Molecule Targeted Cancer Therapy Product Offered
  11.15.3 Amgen Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Amgen Main Business Overview
  11.15.5 Amgen Latest Developments
11.16 AbbVie
  11.16.1 AbbVie Company Information
  11.16.2 AbbVie Small Molecule Targeted Cancer Therapy Product Offered
  11.16.3 AbbVie Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 AbbVie Main Business Overview
  11.16.5 AbbVie Latest Developments
11.17 Eli Lilly
  11.17.1 Eli Lilly Company Information
  11.17.2 Eli Lilly Small Molecule Targeted Cancer Therapy Product Offered
  11.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Eli Lilly Main Business Overview
  11.17.5 Eli Lilly Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Small MoleculeTargeted CancerTherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Small MoleculeTargeted CancerTherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecules
Table 5. Major Players of Small Molecule Drug Conjugates
Table 6. Small MoleculeTargeted CancerTherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Small MoleculeTargeted CancerTherapy Market Size byType (2020-2025) & ($ millions)
Table 8. Global Small MoleculeTargeted CancerTherapy Market Size Market Share byType (2020-2025)
Table 9. Small MoleculeTargeted CancerTherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Small MoleculeTargeted CancerTherapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Small MoleculeTargeted CancerTherapy Market Size Market Share by Application (2020-2025)
Table 12. Global Small MoleculeTargeted CancerTherapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Small MoleculeTargeted CancerTherapy Revenue Market Share by Player (2020-2025)
Table 14. Small MoleculeTargeted CancerTherapy Key Players Head office and Products Offered
Table 15. Small MoleculeTargeted CancerTherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small MoleculeTargeted CancerTherapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Small MoleculeTargeted CancerTherapy Market Size Market Share by Region (2020-2025)
Table 20. Global Small MoleculeTargeted CancerTherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Small MoleculeTargeted CancerTherapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Small MoleculeTargeted CancerTherapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Small MoleculeTargeted CancerTherapy Market Size Market Share by Country (2020-2025)
Table 24. Americas Small MoleculeTargeted CancerTherapy Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Small MoleculeTargeted CancerTherapy Market Size Market Share byType (2020-2025)
Table 26. Americas Small MoleculeTargeted CancerTherapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Small MoleculeTargeted CancerTherapy Market Size Market Share by Application (2020-2025)
Table 28. APAC Small MoleculeTargeted CancerTherapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Small MoleculeTargeted CancerTherapy Market Size Market Share by Region (2020-2025)
Table 30. APAC Small MoleculeTargeted CancerTherapy Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Small MoleculeTargeted CancerTherapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Small MoleculeTargeted CancerTherapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Small MoleculeTargeted CancerTherapy Market Size Market Share by Country (2020-2025)
Table 34. Europe Small MoleculeTargeted CancerTherapy Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Small MoleculeTargeted CancerTherapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small MoleculeTargeted CancerTherapy
Table 40. Key Market Challenges & Risks of Small MoleculeTargeted CancerTherapy
Table 41. Key IndustryTrends of Small MoleculeTargeted CancerTherapy
Table 42. Global Small MoleculeTargeted CancerTherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Small MoleculeTargeted CancerTherapy Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Small MoleculeTargeted CancerTherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Small MoleculeTargeted CancerTherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Roche Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 47. Roche Small MoleculeTargeted CancerTherapy Product Offered
Table 48. Roche Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Roche Main Business
Table 50. Roche Latest Developments
Table 51. Gilead Sciences Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 52. Gilead Sciences Small MoleculeTargeted CancerTherapy Product Offered
Table 53. Gilead Sciences Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Gilead Sciences Main Business
Table 55. Gilead Sciences Latest Developments
Table 56. Boehringer Ingelheim Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 57. Boehringer Ingelheim Small MoleculeTargeted CancerTherapy Product Offered
Table 58. Boehringer Ingelheim Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Boehringer Ingelheim Main Business
Table 60. Boehringer Ingelheim Latest Developments
Table 61. Abbott Laboratories Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 62. Abbott Laboratories Small MoleculeTargeted CancerTherapy Product Offered
Table 63. Abbott Laboratories Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Abbott Laboratories Main Business
Table 65. Abbott Laboratories Latest Developments
Table 66. Bayer AG Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 67. Bayer AG Small MoleculeTargeted CancerTherapy Product Offered
Table 68. Bayer AG Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Bayer AG Main Business
Table 70. Bayer AG Latest Developments
Table 71. GSK Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 72. GSK Small MoleculeTargeted CancerTherapy Product Offered
Table 73. GSK Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. GSK Main Business
Table 75. GSK Latest Developments
Table 76. AstraZeneca Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 77. AstraZeneca Small MoleculeTargeted CancerTherapy Product Offered
Table 78. AstraZeneca Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Latest Developments
Table 81. Johnson & Johnson Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 82. Johnson & Johnson Small MoleculeTargeted CancerTherapy Product Offered
Table 83. Johnson & Johnson Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Latest Developments
Table 86.Teva Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 87.Teva Small MoleculeTargeted CancerTherapy Product Offered
Table 88.Teva Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89.Teva Main Business
Table 90.Teva Latest Developments
Table 91. Pfizer Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 92. Pfizer Small MoleculeTargeted CancerTherapy Product Offered
Table 93. Pfizer Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. Allergan Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 97. Allergan Small MoleculeTargeted CancerTherapy Product Offered
Table 98. Allergan Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Allergan Main Business
Table 100. Allergan Latest Developments
Table 101. Merck Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 102. Merck Small MoleculeTargeted CancerTherapy Product Offered
Table 103. Merck Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. Novartis Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 107. Novartis Small MoleculeTargeted CancerTherapy Product Offered
Table 108. Novartis Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Novartis Main Business
Table 110. Novartis Latest Developments
Table 111. Sanofi Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 112. Sanofi Small MoleculeTargeted CancerTherapy Product Offered
Table 113. Sanofi Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Sanofi Main Business
Table 115. Sanofi Latest Developments
Table 116. Amgen Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 117. Amgen Small MoleculeTargeted CancerTherapy Product Offered
Table 118. Amgen Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Amgen Main Business
Table 120. Amgen Latest Developments
Table 121. AbbVie Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 122. AbbVie Small MoleculeTargeted CancerTherapy Product Offered
Table 123. AbbVie Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. AbbVie Main Business
Table 125. AbbVie Latest Developments
Table 126. Eli Lilly Details, CompanyType, Small MoleculeTargeted CancerTherapy Area Served and Its Competitors
Table 127. Eli Lilly Small MoleculeTargeted CancerTherapy Product Offered
Table 128. Eli Lilly Small MoleculeTargeted CancerTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Small MoleculeTargeted CancerTherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small MoleculeTargeted CancerTherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Small MoleculeTargeted CancerTherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Small MoleculeTargeted CancerTherapy Sales Market Share by Country/Region (2024)
Figure 8. Small MoleculeTargeted CancerTherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Small MoleculeTargeted CancerTherapy Market Size Market Share byType in 2024
Figure 10. Small MoleculeTargeted CancerTherapy in Lymphoma
Figure 11. Global Small MoleculeTargeted CancerTherapy Market: Lymphoma (2020-2025) & ($ millions)
Figure 12. Small MoleculeTargeted CancerTherapy in Melanoma
Figure 13. Global Small MoleculeTargeted CancerTherapy Market: Melanoma (2020-2025) & ($ millions)
Figure 14. Small MoleculeTargeted CancerTherapy in Multiple Myeloma
Figure 15. Global Small MoleculeTargeted CancerTherapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 16. Small MoleculeTargeted CancerTherapy in Breast Cancer
Figure 17. Global Small MoleculeTargeted CancerTherapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 18. Small MoleculeTargeted CancerTherapy in Prostate Cancer
Figure 19. Global Small MoleculeTargeted CancerTherapy Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 20. Small MoleculeTargeted CancerTherapy in Others
Figure 21. Global Small MoleculeTargeted CancerTherapy Market: Others (2020-2025) & ($ millions)
Figure 22. Global Small MoleculeTargeted CancerTherapy Market Size Market Share by Application in 2024
Figure 23. Global Small MoleculeTargeted CancerTherapy Revenue Market Share by Player in 2024
Figure 24. Global Small MoleculeTargeted CancerTherapy Market Size Market Share by Region (2020-2025)
Figure 25. Americas Small MoleculeTargeted CancerTherapy Market Size 2020-2025 ($ millions)
Figure 26. APAC Small MoleculeTargeted CancerTherapy Market Size 2020-2025 ($ millions)
Figure 27. Europe Small MoleculeTargeted CancerTherapy Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size 2020-2025 ($ millions)
Figure 29. Americas Small MoleculeTargeted CancerTherapy Value Market Share by Country in 2024
Figure 30. United States Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Small MoleculeTargeted CancerTherapy Market Size Market Share by Region in 2024
Figure 35. APAC Small MoleculeTargeted CancerTherapy Market Size Market Share byType (2020-2025)
Figure 36. APAC Small MoleculeTargeted CancerTherapy Market Size Market Share by Application (2020-2025)
Figure 37. China Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. India Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Small MoleculeTargeted CancerTherapy Market Size Market Share by Country in 2024
Figure 44. Europe Small MoleculeTargeted CancerTherapy Market Size Market Share byType (2020-2025)
Figure 45. Europe Small MoleculeTargeted CancerTherapy Market Size Market Share by Application (2020-2025)
Figure 46. Germany Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 47.France Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size Market Share byType (2020-2025)
Figure 53. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 57.Turkey Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Small MoleculeTargeted CancerTherapy Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 60. APAC Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 61. Europe Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 63. United States Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 64. Canada Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 65. Mexico Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 66. Brazil Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 67. China Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 68. Japan Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 69. Korea Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 71. India Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 72. Australia Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 73. Germany Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 74.France Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 75. UK Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 76. Italy Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 77. Russia Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 78. Egypt Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 79. South Africa Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 80. Israel Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 81.Turkey Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)
Figure 82. Global Small MoleculeTargeted CancerTherapy Market Size Market ShareForecast byType (2026-2031)
Figure 83. Global Small MoleculeTargeted CancerTherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 84. GCC Countries Small MoleculeTargeted CancerTherapy Market Size 2026-2031 ($ millions)